This inventor holds 3 USPTO granted patents and 18 published patent applications. Top assignee: Selecta Biosciences, Inc.. Active years: 2015-2021.
Company Filing History:
Years Active: 2015-2021
Title: Innovations by Petr Ilyinskii
Introduction
Petr Ilyinskii is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of synthetic nanocarriers, with a focus on generating immune responses. His work has led to the development of three patents that showcase his innovative approach to immunology.
Latest Patents
Ilyinskii's latest patents include methods for administering synthetic nanocarriers that generate humoral and cytotoxic T lymphocyte responses. These methods are designed to enhance immune responses in subjects, providing a promising avenue for therapeutic applications. Another patent focuses on dose selection of adjuvanted synthetic nanocarriers, which involves compositions that couple adjuvant materials with synthetic nanocarriers to improve efficacy.
Career Highlights
Petr Ilyinskii is currently associated with Selecta Biosciences, Inc., where he continues to advance his research in the field of immunology. His work is characterized by a commitment to developing innovative solutions that address complex medical challenges.
Collaborations
Some of his notable coworkers include Grayson B Lipford and Charles M Zepp, who contribute to the collaborative environment that fosters innovation at Selecta Biosciences.
Conclusion
Petr Ilyinskii's contributions to the field of synthetic nanocarriers and immunology highlight his role as a leading inventor. His patents reflect a dedication to advancing medical science through innovative approaches.